D. J. STEPHENS, M.D.; NOLAN L. KALTREIDER, M.D.
Although venesection has been used for many years as an emergency measure in erythremia, its general use as a therapeutic agent in this disease has been considered contraindicated on the grounds that reduction of the blood level by this means would act as a further stimulus to erythrocyte production.1 Recent investigations, however, have indicated that this assumption may be unwarranted. Falconer2 has shown that the repeated removal of from 200 to 600 c.c. of blood at intervals of from a few days to three weeks did not increase the reticulocyte percentage above normal limits. Reimann and Breuer3 have studied the
Learn more about subscription options.
Register Now for a free account.
STEPHENS DJ, KALTREIDER NL. THE THERAPEUTIC USE OF VENESECTION IN POLYCYTHEMIA(THE THERAPEUTIC USE OF VENESECTION IN POLYCYTHEMIA*). Ann Intern Med. 1937;10:1565–1581. doi: 10.7326/0003-4819-10-10-1565
Download citation file:
Published: Ann Intern Med. 1937;10(10):1565-1581.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only